Evony - The King's Return(@Evony_TKR) 's Twitter Profile Photo

🔥The PC version of Evony, which has exceeded 160 million downloads worldwide, is now available! 😍 Download for free and create your own empire! 💪

account_circle
Let's Win Pancreatic Cancer 💜(@letswinpc) 's Twitter Profile Photo

Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial. letswinpc.org/research/mrna-…

account_circle
Freddie⚡️ ⓌOO⚡️(@Bullsey71772634) 's Twitter Profile Photo

This is really mindblowing.. 'Designed for All operable solid tumors'. Imagine the market for this cancervaccine.. 20 years in the making. We Will get rewarded soon when approval comes and lawsuit won. Buckle up for a crazy ride.. 🎢 🚀$NWBO

This is really mindblowing.. 'Designed for All operable solid tumors'. Imagine the market for this cancervaccine.. 20 years in the making. We Will get rewarded soon when approval comes and lawsuit won. Buckle up for a crazy ride.. 🎢 🚀$NWBO #stockpicknr1
account_circle
Lumanity(@lumanity) 's Twitter Profile Photo

It's not too late to register for tomorrow's webinar discussing strategies and positioning vaccine programs/platforms for investment or partnerships. buff.ly/3qdWfwM

progress

It's not too late to register for tomorrow's webinar discussing #clinicaldevelopment strategies and positioning #cancervaccine programs/platforms for investment or partnerships. buff.ly/3qdWfwM 

#oncology #cancer #cancerprogress #pharmaceuticals
account_circle
🇺🇸🤝🇺🇦eastvillagetwt(@eastvillagetwt) 's Twitter Profile Photo

NIH is showing strong support here w/a $7.3 million grant, one of a few grants to UCLA by NIH, as & related immunotherapy research has been a major success at UCLA

$NWBO

account_circle
The ROS1ders, Inc.(@ros1cancer) 's Twitter Profile Photo

Please consider applying for the first-ever ROS1+ Cancer Innovation Award. Deadline for LOI submission is March 31, 2023.
prlog.org/12952103

Please consider applying for the first-ever ROS1+ Cancer Innovation Award.  Deadline for LOI submission is March 31, 2023.
prlog.org/12952103
account_circle
🇩🇰 The Danish Dude 🇩🇰(@FlemmingBruce) 's Twitter Profile Photo

$NWBO

Dr. Steven Toms mentioning the extreme efficacy shown at Dr. Linda Liaus UCLA SPORE combo trial, combining DCVax-L with Mercks Keytruda checkpoint inhibitor.

youtube.com/watch?v=cU_-1E…

account_circle
SouthernTrading(@SouthernDrive21) 's Twitter Profile Photo

$nwbo
'Liau, a neuro-oncologist, said the new facility will enable researchers to create personalized vaccines and cell therapies for a much larger number of patients.'
stemcell.ucla.edu/news/ucla-rece…

account_circle
CNS Pharma(@cns_pharma) 's Twitter Profile Photo

We are developing anti-cancer drug candidates for the treatment of primary and metastatic brain and CNS cancers. bit.ly/3npZn3X

$CNSP

account_circle
Joan Lappin CFA(@joanlappin) 's Twitter Profile Photo

This new SPORE grant to UCLA to continue its combo trials uses DCVAX as a Standard of Care (SOC) baseline for all patients + a combo with Merck's Keytruda or another drug. Read this with care. It is impt. connect.uclahealth.org/2022/09/14/bra…

account_circle
Roberta Horgan 🇮🇪 🇺🇦(@HorganRoberta) 's Twitter Profile Photo

'In one patient with a strong response, T cells produced by the vaccine even appeared to eliminate a small tumor that had spread to the liver. These results suggest that the T cells activated by the vaccines kept the pancreatic cancer in check.'


account_circle
Allen Turner(@AllenTurner206) 's Twitter Profile Photo

Impressive LCM strategy before initial approval! $nwbo

DCVax-L + Poly-ICLC. Est primary completion Jan 2024. Unpublished interim results: ~50% survival at >8 YEARS.

DCVax-L + PD-1. Est primary completion Aug 2024. Unpublished interim results: ~65% survival at >26 mos.

Impressive LCM strategy before initial approval! #dcvax $nwbo

DCVax-L + Poly-ICLC. Est primary completion Jan 2024. Unpublished interim results: ~50% survival at >8 YEARS. 

DCVax-L + PD-1. Est primary completion Aug 2024. Unpublished interim results: ~65% survival at >26 mos.
account_circle
Society for Immunotherapy of Cancer(@sitcancer) 's Twitter Profile Photo

Are you a healthcare provider? You can earn a Certificate in from Society for Immunotherapy of Cancer. Receive comprehensive education in immuno-oncology care with eight expert-led modules. CME, CNE, CPE & MOC credits available.

account_circle
Sara Turle 💙(@SaraTurle) 's Twitter Profile Photo

Pushed the mileage this week with some super sunny days. 60 miles with 322 miles YTD. A privilege to hear about the this week. No guarantees but
. 💙

Pushed the mileage this week with some super sunny days. 60 miles #NHS1000miles with 322 miles YTD. A privilege to hear about the #cancervaccine this week. No guarantees but
#hope. 💙
account_circle
Dr Lennard Lee (Oxford University)(@drlennardlee) 's Twitter Profile Photo

1/x 🧵. Every week there's a new article about the developments of . This one 🗣️ 'Cancer vaccines...a concept torn from plots of a futuristic sci-fi movie, or .. the pages of decades-old utopian novel far ahead of its time. But such wonders of science exist today

account_circle
hypertrust patient data care(@_hypertrust_) 's Twitter Profile Photo

🔬 Exciting news alert! New data on TG4050 at from Transgene. The abstract presents fascinating and hopes for cancer vaccine treatment in solid tumors.

Abstract: bit.ly/45sqC2D. Poster: bit.ly/43PfGuI.

account_circle